• About Us
  • Services
  • Process
  • News
  • Contact
BioPortUSA
  • About Us
    • Our Team
    • Advisory Board
    • Partners
    • Process
    • Client Experience
  • Services
    • Market Assessment
    • Market Launchpad
  • Process
  • News
    • Events
  • Contact
  • About Us
    • Our Team
    • Advisory Board
    • Partners
    • Process
    • Client Experience
  • Services
    • Market Assessment
    • Market Launchpad
  • Process
  • News
    • Events
  • Contact
31 May

BioPortUSA & UK HealthGateway discuss US Market Entry and Brexit

#

Earlier this month, Mark Lesselroth, CEO of BioPortUSA and David Reed, Principal of Reed Business law, had an opportunity to join Jon Wilks our partner at UK HealthGateway to discuss the topic of Brexit and how it could impact US market entry for UK based medtech firms. Given the uncertainty surrounding Brexit combined with the new, stringent requirements set forth in the MDR as outlined by the European Union, UK based medtech firms are facing some potentially daunting times, at least in their own backyard. With that in mind, we discussed the advantages of focusing more of your attention on the US market given our historic relationship and the fact that you are dealing with the largest medtech market in the world. To put things into perspective, last year the  US did approximately $380 Billion dollars in sales. The next closest country was Germany at less than $28 Billion Dollars. The UK was around $7 Billion dollars.

We invite you to listen in to our recording from May 14.

Listen Now

Social Media

  • Twitter
  • LinkedIn
Latest Articles
#
Medica Tech Forum
Nov 5, 2021, 9:58 AM
Zenit invites BioPortUSA to speak at MedTech conference
Nov 2, 2021, 11:51 AM
#
Swiss Start-Up engages BioPortUSA on help with Reimbursement
Oct 28, 2021, 11:44 AM

About BioPortUSA   

BioPort USA

The Gateway For Life Sciences Into The United States

Certification

akkreditiertes beratungsunternehmen

BioPortUSA is certified with RKW Thüringen.

Contact

United States

Mark Lesselroth, CEO

mark(at)bioportusa.com

+1 315 569 0642

BioPortUSA © 2021

About Us   Services    Process    Contact    Privacy